Alexandria Real Estate Equities Aktie News

U.S. equity markets stumbled this week as stretched tech valuations collided with weakening consumer and labor market data, while the economic drag and uncertainty from the ongoing government shutdown build. Now it's real? The shutdown has now halted fiscal flows into several sizable government benefits programs - a sudden onset of fiscal austerity that could have non-trivial disinflationary im...

Alexandria Real Estate (ARE) shares have plunged, creating a potential buying opportunity, as the stock appears deeply oversold after a capitulation-like selloff. ARE faces challenges including oversupply of lab space, weak biotech IPO market, and concerns over a possible dividend cut, but its payout ratio remains reasonable. The REIT offers a nearly 10% dividend yield, trades at a low valuatio...

Dividends are a great way to profit in a sideways or down market. These three stocks are on sale right now, with impressive dividends.

Fiserv (FI) leads decliners with a 49% drop, driven by leadership turmoil, weak consumer spending, and a downgraded quant rating to 'Strong Sell.' Alexandria Real Estate (ARE) and Robert Half (RHI) suffer from sector-specific headwinds, with ARE hurt by biotech weakness and RHI by declining revenue and a negative outlook. Molina Healthcare (MOH) and Baxter (BAX) face earnings cuts and operation...

US equity real estate investment trust indexes dropped during the final week of October. The Dow Jones Equity All REIT index closed the recent week down 3.29%, while the MSCI US REIT (RMZ) index fell 2.88%. The healthcare REIT index was the sole Dow Jones US real estate property sector index to close the week in the black, recording a 1.47% gain.

U.S. equity markets posted mixed performance this week- while long-term yields jumped- after the Federal Reserve cut short-term rates for a second-straight meeting, but reigned in expectations for future cuts. Fed Chair Powell hawkishly pushed back on market expectations, saying that another cut in December was "far" from certain and highlighting "strongly differing views" within the committee....

AI-driven tech stocks dominate 2025 returns, leaving dividend and high-yield ETFs lagging due to limited AI exposure. REITs face mixed fortunes: ARE and DOC struggle with life science oversupply, while IVT, AMT, ADC, and VICI offer attractive dividend growth and value. My current buy list focuses on undervalued REITs and ETFs with strong dividend growth.

Alexandria Real Estate Equities, Inc. is rated a Strong Buy, offering a rare opportunity to acquire a high-quality REIT at a bargain price. ARE's recent 24% price drop is seen as overdone, with recovery expected as oversupply is repurposed and interest rates decline by 2026-2027. Projected FFO/share growth and multiple expansion could drive ARE to $143 by 2030, delivering a 143% gain plus an 8....